Evidence map›Paper›PMID 40918173›Full record

ArticleFood science & nutrition2025

The Iodine Bioavailability and Its Metabolic Response for Kombu and Potassium Iodide Intake in Chinese Adults.

Xiaobing Liu, Jun Wang, Yajie Li, Hongxing Tan, Wei Yu, Junan Yan, Jianhua Piao, Xiaoli Liu, Xiaoguang Yang

Abstract read
In one paragraph

Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaobing LiuNational Institute for Nutrition and Health Chinese Center for Disease Control and Prevention Beijing China.ORCID https://orcid.org/0000-0001-9633-2963
Jun WangShenzhen Polytechnic School of Food and Drug Shenzhen Guangdong China.
Yajie LiChangzhi Medical College Shanxi China.
Hongxing TanShenzhen Chronic Disease Control Center Shenzhen Guangdong China.
Wei YuShenzhen Chronic Disease Control Center Shenzhen Guangdong China.
Junan YanShenzhen Chronic Disease Control Center Shenzhen Guangdong China.
Jianhua PiaoNational Institute for Nutrition and Health Chinese Center for Disease Control and Prevention Beijing China.
Xiaoli LiuShenzhen Chronic Disease Control Center Shenzhen Guangdong China.
Xiaoguang YangNational Institute for Nutrition and Health Chinese Center for Disease Control and Prevention Beijing China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The consumption of kombu plays an important role in the traditional dietary habits of East-Asian countries. However, data on the metabolic profile of kombu-derived iodine remain limited. Totally, 20 Chinese participants (age 19.6 ± 2.7 years) were recruited and allocated to two parallel intervention groups. One consisted of a meal with kombu supplement (providing 993 and 1735 μg iodine), and the other of potassium iodide (KI, containing 547 and 1263 μg iodine) at the two interventions. The iodine bioavailability was assessed based on the 0-24 h urine samples, and the metabolic response was characterized by urinary iodine excretion velocity (UIEV) at 18 time points during the following 48 h. Iodine speciation in kombu was determined by liquid chromatography and inductively coupled plasma mass spectrometry (LC-ICPMS). 18 Chinese participants finally completed this study and two participants dropped out. The 0-24 h urinary iodine concentration (UIC) was consistently lower in the kombu group compared to the KI group (95 μg/L vs. 113 μg/L,

Indexed as

iodine bioavailabilitykombuorganically bound iodineurinary iodine excretion velocity

Identifiers

PMID40918173
PMCPMC12411244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.